SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-23-000045
Filing Date
2023-05-04
Accepted
2023-05-04 07:04:10
Documents
15
Period of Report
2023-05-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20230504.htm   iXBRL 8-K 36689
2 EX-99.1 sndaacceptancepressrelease.htm EX-99.1 22799
6 GRAPHIC imagea.jpg GRAPHIC 152460
7 optn-20230504_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-23-000045.txt   436967

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20230504.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20230504_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20230504_pre.xml EX-101.PRE 13046
9 EXTRACTED XBRL INSTANCE DOCUMENT optn-20230504_htm.xml XML 9864
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 23886391
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences